Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2007
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238772 Use of Metronidazole for Preparing a Pharmaceutical Composition for Treating a Cutaneous Vascularisation Disorder
10/11/2007US20070238769 Bone Densifying Agent Characterized By Use Of Cathepsin K Inhibitor With Pth
10/11/2007US20070238757 Novel treatment
10/11/2007US20070238756 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
10/11/2007US20070238749 Alpha2delta ligands for the treatment of fibromyalgia and other disorders
10/11/2007US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use
10/11/2007US20070238714 Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
10/11/2007US20070238677 Pharmaceutical Composition Containing Hshrd3
10/11/2007US20070238641 Pharmaceutical Combined Preparation Containing a Therapeutic Protein
10/11/2007US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
10/11/2007US20070237836 Strontium compound for treatment of sub-dermal soft tissue pain
10/11/2007US20070237835 Peritoneal Dialysis Solution
10/11/2007US20070237833 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237832 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
10/11/2007US20070237787 Methods for use of tslp and agonists and antagonists thereof
10/11/2007US20070237763 Compositions and methods for the treatment of cancer
10/11/2007CA2645242A1 Combinations of therapeutic agents for treating cancer
10/11/2007CA2644143A1 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer
10/11/2007CA2641951A1 Combination of organic compounds
10/10/2007EP1842556A1 Therapeutic agent for attention-deficit hyperactivity disorder
10/10/2007EP1842555A1 Tolerance development inhibitor for narcotic analgesic agent
10/10/2007EP1842550A2 Composition for inducing immunotolerance
10/10/2007EP1842538A2 Treatment for Raynaud's Phenomenon
10/10/2007EP1841730A1 Cathepsin k inhibitors and atherosclerosis
10/10/2007EP1841462A2 Growth factor therapy mobilization of stem cells into the peripheral blood
10/10/2007EP1841460A2 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/10/2007EP1841459A2 Use of a dihydroim1dazopyrazine derivative for treating or preventing pain
10/10/2007EP1841458A1 Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
10/10/2007EP1841415A2 Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
10/10/2007EP1841414A1 Rosiglitazone and metformin formulations
10/10/2007EP1603544B1 Treatment of intestinal conditions with n-2,3,3-tetramethylbicyclo 2.2.1 heptan-2-amine
10/10/2007EP1511509B1 Compositions and methods for treating diabetes
10/10/2007EP1487829B1 Thiadiazolylpiperazine derivatives useful for treating or preventing pain
10/10/2007EP1485090B1 Combinations comprising an epothilone derivative and an imidazotetrazinone
10/10/2007EP1399153B1 Pharmaceutical composition comprising orlistat and a fatty acid or salt thereof
10/10/2007EP1319007B9 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/10/2007EP1300159B1 Remedies for cancer
10/10/2007EP1261317B1 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
10/10/2007EP1231927B1 Compositions comprising vernix and an uv protectant and their use
10/10/2007EP1229906B1 Mesoprogestins for the treatment and prevention of benign hormone dependent gynecological disorders
10/10/2007EP1181304B1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/10/2007EP1012271B1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
10/10/2007CN101052718A Mutated amyloid protein
10/10/2007CN101052420A Combination drug for treating autoimmune disease
10/10/2007CN101052407A Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
10/10/2007CN101052384A Non-aqueous transdermal absorption prepn. contg. non-steroid antiphlogistic analgesic
10/10/2007CN101052312A Compositions for improving oxidative status in companion animals
10/10/2007CN101050199A (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor
10/10/2007CN100341574C Novel use of cell wall skeleton of red nocar-ray-fungus for treating liver diseases
10/10/2007CN100341573C Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
10/10/2007CN100341572C Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
10/10/2007CN100341509C Medicinal composition for mitigating blood lipid or lowering blood homocysteine
10/10/2007CN100341506C Medical compositions containing aspirin
10/10/2007CN100341496C Preventive or therapeutic agent for kidney disease
10/10/2007CN100341491C Film coating
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279575 Such as 2-(2-aminopyrimidin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one hydrochloride; for treatment of cell proliferative disorders/cancer; kits
10/09/2007US7279502 Such as prostate cancer, prostatitis and benign prostatic hyperplasia; ethyl endcapped hepta- and nona-tetramethylenediamines and 1,2-bis(4-(ethylamino)butylaminomethyl)cyclopropane
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279487 Hydroxynaphthyridinone carboxamides useful as HIV integrase inhibitors
10/09/2007US7279485 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
10/09/2007US7279479 Method for the treatment of heart failure
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279473 Administered singly or in combination with a second antineoplastic agent; cyclin-dependent kinase inhibitors, antiproliferative agents; coupling and cyclization of a 1-aminopyridazinium salt with a 2-alkylthio-4-alkynyl pyrimidine compound
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279468 Integrin ligands
10/09/2007US7279459 Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007US7279330 Method for identifying modulating compounds of neurotransmitters
10/09/2007US7279324 Nucleic acid encoding G-protein coupled receptor with modified DRY motif
10/09/2007US7279307 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18
10/09/2007US7279299 Contacting a candidate molecule with a polypeptide, Polypeptide retains the ability to dephosphorylate an activated MAP-kinase; detecting the presence or absence of binding of the candidate molecule to the polypeptide, and determining whether the candidate molecule interacts with the DSP-10 polypeptide
10/09/2007US7279185 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
10/09/2007US7279179 Liposome-entrapped topoisomerase inhibitors
10/09/2007US7279160 Combinations of DR5 antibodies and other therapeutic agents
10/09/2007US7279158 Methods for the treatment of inflammatory joint disease
10/09/2007US7279157 Treating with active material having heavy chain variable region of amino acid sequence 7 and light chain variable region of sequence 8; psoriasis, multiple sclerosis, Crohn's disease
10/09/2007CA2232855C Pharmaceutical formulation
10/04/2007WO2007112065A2 Methods for treating cognitive and other disorders
10/04/2007WO2007111958A2 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods
10/04/2007WO2007111371A1 Agent for amelioration of hyperesthetic skin itching
10/04/2007WO2007110977A1 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical
10/04/2007WO2007110811A2 Use of the staudinger ligation in in vivo assembly of a biologically active compound
10/04/2007WO2007110226A1 Stable oral pharmaceutical composition containing thyroid hormone receptor agonists
10/04/2007WO2007092616A3 Combinations comprising hcv protease inhibitor(s) and hcv polymerase inhibitor(s), and methods of treatment related thereto
10/04/2007WO2007088343A8 Granular material comprising water- insoluble inorganic phosphate binders
10/04/2007WO2007058805A3 Compositions and methods for treating cns disorders
10/04/2007WO2007049098A3 Therapeutic formulations for the treatment of beta-amyloid related diseases
10/04/2007WO2006084174A3 Improved bioavailability and improved delivery of alkaline pharmaceutical drugs
10/04/2007WO2006030306A8 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder
10/04/2007WO2005032462A3 Glucocerebroside treatment of disease
10/04/2007WO2005030133A3 Treatment with agonists of toll-like receptors
10/04/2007WO2004097000A3 Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions
10/04/2007US20070232692 Method of Treating Cancer Using Dithiocarbamate Derivatives
10/04/2007US20070232637 Combinations Comprising Antimuscarinic Agents and Pde4 Inhibitors
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232574 2-Oxothiazolidine 4-Carboxylic acid compounds for promoting desquamation of the skin
10/04/2007US20070232560 Treatment of skin with adenosine or adenosine analog
1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 1151